Bio-Rad Laboratories (BIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 517,000 | 507,200 | 529,800 | 395,800 | 369,300 |
| Marketable Securities | 1,101,500 | 1,057,500 | 1,010,900 | 1,022,800 | 1,004,500 |
| Receivables | 441,800 | 426,200 | 460,600 | 464,700 | 469,900 |
| Inventories | 780,600 | 770,500 | 740,700 | 783,200 | 798,800 |
| Other current assets | 31,800 | 30,700 | 27,700 | 23,500 | 19,000 |
| TOTAL | $3,020,500 | $2,942,100 | $2,906,200 | $2,842,000 | $2,811,100 |
| Non-Current Assets | |||||
| PPE Net | 517,900 | 527,500 | 539,900 | 540,200 | 549,700 |
| Investments And Advances | 5,723,600 | 5,311,800 | 6,103,600 | 5,057,800 | 5,576,500 |
| Intangibles | 734,300 | 743,900 | 754,100 | 967,100 | 978,500 |
| Other Non-Current Assets | 255,700 | 264,699 | 272,700 | 289,300 | 298,300 |
| TOTAL | $7,231,500 | $6,847,899 | $7,670,300 | $6,854,400 | $7,403,000 |
| Total Assets | $10,252,000 | $9,790,000 | $10,576,500 | $9,696,400 | $10,214,100 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 400,700 | 400,500 | 1,300 | 1,300 | 1,300 |
| Accounts payable and accrued liabilities | 143,500 | 133,100 | 129,000 | 128,800 | 139,300 |
| Accrued Expenses | 150,500 | 148,400 | 172,300 | 182,800 | 157,800 |
| Other current liabilities | 158,800 | 153,900 | 141,700 | 127,800 | 175,000 |
| TOTAL | $961,300 | $917,000 | $517,000 | $522,300 | $548,900 |
| Non-Current Liabilities | |||||
| Long Term Debt | 803,000 | 802,900 | 1,201,700 | 1,201,400 | 1,201,100 |
| Other Non-Current Liabilities | 331,600 | 337,000 | 344,800 | 363,300 | 374,400 |
| TOTAL | $2,116,800 | $2,021,700 | $2,605,900 | $2,437,300 | $2,536,500 |
| Total Liabilities | $3,078,100 | $2,938,700 | $3,122,900 | $2,959,600 | $3,085,400 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 26,738 | 26,762 | 26,990 | 26,975 | 27,062 |
| Retained earnings | 8,020,600 | 7,649,200 | 8,176,300 | 7,456,300 | 7,798,200 |
| Other shareholders' equity | -271,600 | -235,400 | -188,700 | -166,400 | -154,100 |
| TOTAL | $7,173,900 | $6,851,300 | $7,453,600 | $6,736,800 | $7,128,700 |
| Total Liabilities And Equity | $10,252,000 | $9,790,000 | $10,576,500 | $9,696,400 | $10,214,100 |